Abstract
Mechanical circulatory support (MCS) plays a key role in the management of patients with end stage heart failure as a bridge to transplantation and in select cases as destination therapy. A small number provide continuous flow MCS. The effect of continuous flow MCS on the right ventricle (RV) has not been clear, with the suggestion that it could adversely affect RV function over the longer term. In this study we therefore documented the effect of a 3rd generation LV assist device (Ventrassist LVAS) on both the left ventricle (LV) and RV over a 3 month period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
